Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between lung cancer cells and macrophages contributes to traditional Chinese medicine Feiyanning-induced anti-tumor activities by suppressing M2 macrophage polarization. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37667564 | PubTator, text mining | PubMed |
| Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer. | BMC Med | 2023 | 37667257 | PubTator, text mining | PubMed |
| TAM family kinases as therapeutic targets at the interface of cancer and immunity. | Nat Rev Clin Oncol | 2023 | 37667010 | PubTator, text mining | PubMed |
| Phubbing behavior, personality, and use of instagram by Brazilian adults: a correlational and predictive study. | Psicol Reflex Crit | 2023 | 37665514 | PubTator, text mining | PubMed |
| AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages. | Cell Rep | 2023 | 37659081 | PubTator, text mining | PubMed |
| FBXW7 in breast cancer: mechanism of action and therapeutic potential. | J Exp Clin Cancer Res | 2023 | 37658431 | PubTator, text mining | PubMed |
| Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. | J Exp Clin Cancer Res | 2023 | 37658402 | PubTator, text mining | PubMed |
| Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer. | Theranostics | 2023 | 37649596 | PubTator, text mining | PubMed |
| Revealing Complex Functional Topology Brain Network Correspondences Between Humans and Marmosets. | bioRxiv | 2023 | 37645890 | PubTator, text mining | PubMed |
| Interferome signature dynamics during the anti-dengue immune response: a systems biology characterization. | Front Immunol | 2023 | 37638052 | PubTator, text mining | PubMed |
| A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019. | Microorganisms | 2023 | 37630598 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Case report: Atomoxetine improves chronic pain with comorbid post-traumatic stress disorder and attention deficit hyperactivity disorder. | Front Psychiatry | 2023 | 37608999 | PubTator, text mining | PubMed |
| Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy. | J Nanobiotechnology | 2023 | 37608298 | PubTator, text mining | PubMed |
| A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov. | Discov Oncol | 2023 | 37603124 | PubTator, text mining | PubMed |
| TAM receptors in phagocytosis: Beyond the mere internalization of particles. | Immunol Rev | 2023 | 37596991 | PubTator, text mining | PubMed |
| Challenges and new technologies in adoptive cell therapy. | J Hematol Oncol | 2023 | 37596653 | PubTator, text mining | PubMed |
| YAP/TAZ: Molecular pathway and disease therapy. | MedComm (2020) | 2023 | 37576865 | PubTator, text mining | PubMed |
| Weighted gene coexpression network analysis and machine learning reveal oncogenome associated microbiome plays an important role in tumor immunity and prognosis in pan-cancer. | J Transl Med | 2023 | 37573394 | PubTator, text mining | PubMed |
| Navigating the Blood-Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases. | Int J Mol Sci | 2023 | 37569410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=16